Catalysts for Somerset Therapeutics LLC
28 tracked
Apr 1, 2026
approval
PROCHLORPERAZINE EDISYLATE — FDA approval
PROCHLORPERAZINE EDISYLATE
→
Mar 25, 2026
recall
SOMERSET THERAPEUTICS LLC recall (Cls II)
Somerset Therapeutics LLC
→
Jan 29, 2026
approval
RILPIVIRINE HYDROCHLORIDE — FDA approval
rilpivirine hydrochloride ODT
→
Jan 20, 2026
approval
SACUBITRIL AND VALSARTAN (SACUBITRIL) — FDA approval
SACUBITRIL AND VALSARTAN
→
Jan 14, 2026
approval
ELTROMBOPAG OLAMINE — FDA approval
ELTROMBOPAG OLAMINE
→
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
→
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
→
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
→
Dec 22, 2025
approval
NALBUPHINE HYDROCHLORIDE — FDA approval
NALBUPHINE HYDROCHLORIDE
→
Dec 22, 2025
approval
NALBUPHINE HYDROCHLORIDE — FDA approval
NALBUPHINE HYDROCHLORIDE
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Sep 26, 2025
approval
ACETYLCYSTEINE — FDA approval
ACETYLCYSTEINE
→
Sep 23, 2025
approval
LEUPROLIDE ACETATE — FDA approval
LEUPROLIDE ACETATE
→
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
→
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
→
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
→
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
→
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
→
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
→
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
→
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
→
Feb 12, 2025
approval
ACETYLCYSTEINE — FDA approval
ACETYLCYSTEINE
→
Jan 30, 2025
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jan 8, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
→
Sep 19, 2024
approval
NALBUPHINE HYDROCHLORIDE — FDA approval
NALBUPHINE HYDROCHLORIDE
→
Sep 19, 2024
approval
NALBUPHINE HYDROCHLORIDE — FDA approval
NALBUPHINE HYDROCHLORIDE
→
Sep 13, 2024
approval
PROCHLORPERAZINE EDISYLATE — FDA approval
PROCHLORPERAZINE EDISYLATE
→
Aug 13, 2021
approval
LEUPROLIDE ACETATE — FDA approval
LEUPROLIDE ACETATE
→